Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Valproic acid for adenomyosis-associated pelvic pain
2025-523076-23-00Phase 2Authorised
- Sponsor
- CCDRD Cooperative Clinical Drug Research and Development AG, Nadezhda Reproductive Science OOD
- Start
- Aug 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in adenomyosis comparing Valproic acid with Placebo (2 arms). Primary endpoints: Change in adenomyosis-associated pelvic pain and Rescue analgesic use. Planned start Aug 2026; status: authorised.
02
Drugs
valproic acid
03
Conditions
adenomyosis
Beyond the preview
Go deeper on 2025-523076-23-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2025-523076-23-00.